ECSP961731A - Vaccines - Google Patents

Vaccines

Info

Publication number
ECSP961731A
ECSP961731A ECSP961731A ECSP961731A EC SP961731 A ECSP961731 A EC SP961731A EC SP961731 A ECSP961731 A EC SP961731A EC SP961731 A ECSP961731 A EC SP961731A
Authority
EC
Ecuador
Prior art keywords
vaccines
sterol
antigen
immune
composition containing
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Nathalie Marie Garcon
Josephe Claude Garcon
Martin Friede
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961731 priority Critical patent/ECSP961731A/en
Publication of ECSP961731A publication Critical patent/ECSP961731A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Una composición de vacuna que contiene un antígeno, una fracción activa saponina inmunológica y un esterol.A vaccine composition containing an antigen, an immune saponin active fraction and a sterol.

ECSP961731 1996-04-23 1996-04-23 Vaccines ECSP961731A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961731 ECSP961731A (en) 1996-04-23 1996-04-23 Vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961731 ECSP961731A (en) 1996-04-23 1996-04-23 Vaccines

Publications (1)

Publication Number Publication Date
ECSP961731A true ECSP961731A (en) 1997-11-04

Family

ID=42042461

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961731 ECSP961731A (en) 1996-04-23 1996-04-23 Vaccines

Country Status (1)

Country Link
EC (1) ECSP961731A (en)

Similar Documents

Publication Publication Date Title
ES2140076T3 (en) VACCINES CONTAINING A SAPONIN AND A STEROL.
NO991524L (en) vaccinations
DK0865297T3 (en) Vaccine compositions for intranasal administration comprising chitosan and its use
EA199800946A1 (en) CONCENTRATED ANTIBODY PREPARATION
GB9713156D0 (en) Vaccines
IL90058A0 (en) Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies
DK0527760T3 (en) Methods and Preparations for Vaccination against HIV
FI934133A7 (en) gp160 derivatives and vaccines based on gp160 or its derivatives containing an adjuvant
ATE249841T1 (en) IMMUNOGENIC PREPARATIONS
SE9604581D0 (en) An agent against cancer and virus infections
ATE253641T1 (en) ANTIGENIC PREPARATIONS
ATE193974T1 (en) CHLAMYDIA VACCINES
WO1998040097A3 (en) Bovine respiratory and enteric coronavirus as a vaccine
ECSP961731A (en) Vaccines
AU3991899A (en) Verotoxin b subunit for immunization
ATE329615T1 (en) BORRELIA BURGDORFERI BACTERIN
UA42741C2 (en) Peptide of mastitis vaccine (variants), the peptide of complex antigenic idea (variants), pharmaceutical composition (variants)
AU6435596A (en) Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
ES2141044B1 (en) OXIBUTININE THERAPY.
NZ316110A (en) vaccine containing an antigen from H. Influenzae and an antigen from influenza virus
FR2698271B1 (en) Bovine leukemia virus vaccine, new immunogenic peptide and vaccination kit.